Catenaa, Tuesday, July 29, 2025- AstraZeneca has increasing business in the US with 50% revenue expected from the state side by 2030, amidst reports that the UK-listed company might come to Wall Street. CEO Pascal Soriot on Tuesday said the UK-listed company had many reasons to be in the US, adding that it was “rapidly […]